KOREAN
Company Business R & D Investors

Global Stem Cell Company

Investors

Notice IR
Disclosure Information Stock Information IR Resource Center IR Letter & FAQ
PR
Press Release PR Resource Center

IR Letter & FAQ

InvestorsIRIR Letter & FAQ

ir@kangstem.com, 02-888-1590

목록으로

[뉴스1] 강스템, 4분기 허가신청…첫 아토피 줄기세포약 나올까 (19.06.05)

2019.06.05
[뉴스1] 강스템, 4분기 허가신청…첫 아토피 줄기세포약 나올까 (19.06.05)

[단독]강스템, 4분기 허가신청…첫 아토피 줄기세포약 나올까


http://news1.kr/articles/?3638598




목록으로

  [의학신문] BIO USA 참가 한국 기업, ‘바이오 한류’를 외치다 (19.06.06)   [비즈니스포스트] 강경선, 강스템바이오텍 아토피 치료제로 ‘제2 셀트리온’ 꿈꾼다 (19.06.03)
About Us Stock Information Careers Contact Us
Global R&D Center Stem Cell GMP Center Pipeline
TOP
Kangstem Biotech Co., Ltd.
9th Floor, Hongwoo Bldg., 522 Teheran-ro, Gangnam-gu, Seoul

COPYRIGHT © 2015 KANGSTEM BIOTECH ALL RIGHTS RESERVED.
Go
board : irletter : view : : /board/irletter/view